跳至主要内容
临床试验/DRKS00031208
DRKS00031208招募中不适用

Detection of Calcitonin Gene-related Peptide (CGRP) in perilymph of patients with Menière’s Disease

MU Klinik, Universitätsklinikum der Ludwig Maximilians Universität München0 个研究点目标入组 40 人开始时间: 2023年3月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • study group: Menière's Disease (according to the current diagnostic criteria) and indication for cochlear implantation; control group: indication for cochlear implantation

排除标准

  • other vestibular disease, migraines, contact lenses on the day of testing, ophthalmologic disease (other than corrected visual disorder), severe internal, neurologic or psychiatric disease, known hypertension, on the day of testing: ingested antihypertensive medication or 2x detection of hypertension (> 140/90 mmHG), ingestion of painkillers within the last 48 hrs, ingestion of alcohol/nicotine/caffeinated drinks with in the last 12 hrs, pregancy or nursing period

研究者

发起方
MU Klinik, Universitätsklinikum der Ludwig Maximilians Universität München

相似试验